Umoja Biopharma logo

Umoja Biopharma Funding & Investors

Seattle, WA

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer. The company's treatment approach retools a patient’s immune system in vivo to direct potent anti-cancer immune cells to a patient’s tumor, augmenting the body’s natural mechanisms for fighting cancer.

umoja-biopharma.com

Total Amount Raised: $263,000,000

Umoja Biopharma Funding Rounds

  • Series B

    $210,000,000

    Series B Investors

    Cormorant Asset Management
    SoftBank Vision Fund
    CaaS Capital Management
    Temasek
    Presight Capital
    RTW Investments
    Leerink Swann
  • Series A

    $53,000,000

    Series A Investors

    MPM Capital
    Qiming Venture Partners USA
    DCVC
Funding info provided by Diffbot.